Ligand Pharmaceuticals
LGND
#3601
Rank
C$5.02 B
Marketcap
C$255.40
Share price
-1.93%
Change (1 day)
47.48%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.62 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total debt is C$0.62 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Ligand Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$10.19 M24.69%
2023-12-31C$8.17 M-93.13%
2022-12-31C$0.11 B-71.2%
2021-12-31C$0.41 B-28.96%
2020-12-31C$0.58 B-31.47%
2019-12-31C$0.84 B-2.03%
2018-12-31C$0.86 B207.05%
2017-12-31C$0.28 B-1.34%
2016-12-31C$0.28 B2.11%
2015-12-31C$0.28 B23.24%
2014-12-31C$0.22 B2244.63%
2013-12-31C$9.69 M-65.52%
2012-12-31C$28.11 M-8.72%
2011-12-31C$30.8 M34.87%
2010-12-31C$22.84 M-40.15%
2009-12-31C$38.16 M-39.08%
2008-12-31C$62.65 M2814.49%
2007-12-31C$2.14 M-95.61%
2006-12-31C$48.98 M-75.67%
2005-12-31C$0.20 B-3.68%
2004-12-31C$0.20 B-6.61%
2003-12-31C$0.22 B-9.94%
2002-12-31C$0.24 B9.75%
2001-12-31C$0.22 B11.79%
2000-12-31C$0.20 B-0.27%
1999-12-31C$0.20 B40.96%
1998-12-31C$0.14 B86.03%
1997-12-31C$77.44 M-0.11%
1996-12-31C$77.52 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
C$75.41 B 12,003.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$39.84 M-93.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$32.96 B 5,190.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$57.15 B 9,073.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$84.06 B 13,391.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$58.72 B 9,325.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$70.51 B 11,217.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C$13.41 B 2,053.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$63.26 B 10,054.17%๐Ÿ‡บ๐Ÿ‡ธ USA